Argenx price target raised to $670 from $610 at BofA

BofA raised the firm’s price target on Argenx (ARGX) to $670 from $610 and keeps a Buy rating on the shares after a “solid” Q3 beat driven by strong continued growth in gMG. The firm is “highly encouraged” by the continued strong cadence of the Vyvgart launch in gMG, which gives it confidence that the commercial opportunity is larger than we thought, the analyst tells investors.